Predicting melanoma therapy response! BioNTech's Dr. Balogh & Dr. Poran discuss using TCR repertoire & PBMC phenotypes with neoantigen vaccine + anti-PD-1. Responders show more clonal & stable TCRs pre-treatment. Watch: hubs.li/Q03y-PYG0 #Webinar #Immunotherapy #Melanoma
0
0
0
85
0